Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma

類似資料

• Differential expression of PD-L1 between primary and metastatic sites in clear cell Renal Cell Carcinoma
  著者:: Callea, Marcella, 等
  出版事項: (2015)
• Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expression
  著者:: Lalani, Aly-Khan A., 等
  出版事項: (2017)
• Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: Analysis from the treatment approaches in renal cancer global evaluation trial (TARGET)
  著者:: Choueiri, Toni K., 等
  出版事項: (2012)
• Mechanisms of acquired resistance to rapalogs in metastatic renal cell carcinoma
  著者:: Hamieh, Lana, 等
  出版事項: (2018)
• Treatment Selection for Patients With Metastatic Renal Cell Carcinoma
  著者:: Atkins, Michael B., 等
  出版事項: (2009)